We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Shire has announced that it has submitted its dry-eye drug for European marketing approval, a year after it had gained approval in the US for the treatment of dry eye disease.